Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately results in significant slimming. While researc